Mucormycosis (Zygomycosis) in a heart-Kidney trasplant recipient : recovery after posaconazole therapy

ABSTRACT: We describe the case of a diabetic patient who developed a severe invasive fungal infection due to Rhizopus species postoperatively after a dual heart/kidney transplantation with subsequent intensive immunosuppressive therapy. No improvement was noted with amphotericin B (deoxycholate) the...

Full description

Autores:
Tobón Orozco, Ángela María
Arango Arteaga, Myrtha
Fernández, Darío
Restrepo Moreno, Ángela
Tipo de recurso:
Article of journal
Fecha de publicación:
2003
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/24085
Acceso en línea:
http://hdl.handle.net/10495/24085
Palabra clave:
Diabetes mellitus
Trasplante de Riñón
Kidney Transplantation
Zigomicosis
Zygomycosis
Anfotericina B
Amphotericin B
Mucormicosis
Mucormycosis
Rhizopus
Ácido Desoxicólico
Deoxycholic Acid
Receptores de Trasplantes
Transplant Recipients
Riñón
Kidney
Corazón
Heart
Inmunosupresión
Inmunosuppression
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Description
Summary:ABSTRACT: We describe the case of a diabetic patient who developed a severe invasive fungal infection due to Rhizopus species postoperatively after a dual heart/kidney transplantation with subsequent intensive immunosuppressive therapy. No improvement was noted with amphotericin B (deoxycholate) therapy, but salvage treatment with the new azole antifungal posaconazole (200 mg orally 4 times daily) resulted in dramatic clinical improvement as early as 1 week after the initiation of therapy that continued through 23 weeks of treatment, with marked clinical, mycological, and radiological improvements and no adverse events.